Cancer Research on Prevention and Treatment    2022, Vol. 49 Issue (09) : 961-964     DOI: 10.3971/j.issn.1000-8578.2022.21.1534
Research Progress of PNI and CONUT in Breast Cancer
XU XiaoFei1, LI Yang2, CHEN Lingyun1, DAI Heyang3, XUE Jiaojiao1, LI Qingxia1,2
1. Graduate School, Hebei Medical University, Shijiazhuang 050017, China; 2. Fourth Department of Oncology, Hebei General Hospital, Shijiazhuang 050051, China; 3. Graduate School, North China University of Science and Technology, Tangshan 063210, China
Download: PDF(8955 KB)   ( 37 )   HTML ()
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract Breast cancer has overtaken lung cancer as the most common malignancy in women. Although the early diagnostic rate has continuously improved, recurrence and metastasis remain a problem to be solved. Therefore, scientists should search for effective prognostic markers for breast cancer patients and adopt individualized programs for different patients. Studies have shown that cancer prognosis, to a certain extent, is related to the nutrition inflammation index. Preoperative prognostic nutritional index (PNI) and controlled nutritional status (CONUT) are indicators that comprehensively reflect the nutritional level and inflammatory state of patients, respectively. Different from other cancers, the incidence of breast cancer is related to nutritional status, and an extremely high or low score is not conducive to the prognosis of breast cancer patients. This paper reviews the research progress of PNI and CONUT in breast cancer.
Keywords Breast cancer      PNI      CONUT      Prognosis     
ZTFLH:  R737.9  
Fund:International Science and Technology Cooperation Base Construction Project of Hebei Science and Technology Department (No. 19392411D)
Issue Date: 15 September 2022
 Cite this article:   
XU XiaoFei,LI Yang,CHEN Lingyun, et al. Research Progress of PNI and CONUT in Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(09): 961-964.
E-mail this article
E-mail Alert
Articles by authors
XU XiaoFei
LI Yang
CHEN Lingyun
DAI Heyang
XUE Jiaojiao
LI Qingxia
[1] Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics,<br /> 2022[J]. CA Cancer J Clin, 2022, 72(1): 7-33.<br /> [2] Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020:<br /> GLOBOCAN Estimates of Incidence and Mortality Worldwide<br /> for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021,<br /> 71(3): 209-249.<br /> [3] Migita K, Takayama T, Saeki K, et al. The prognostic nutritional<br /> index predicts long-term outcomes of gastric cancer patients<br /> independent of tumor stage[J]. Ann Surg Oncol, 2013, 20(8):<br /> 2647-2654.<br /> [4] Kim SI, Kim SJ, Kim SJ, et al. Prognostic nutritional index and<br /> prognosis in renal cell carcinoma: A systematic review and metaanalysis[<br /> J]. Urol Oncol, 2021, 39(10): 623-630.<br /> [5] Chen L, Bai P, Kong X, et al. Prognostic Nutritional Index (PNI)<br /> in Patients With Breast Cancer Treated With Neoadjuvant<br /> Chemotherapy as a Useful Prognostic Indicator[J]. Front Cell Dev<br /> Biol, 2021, 9: 656741.<br /> [6] Mungmunpuntipantip R, Wiwanitkit V. Prognostic nutritional<br /> index, immune nutritional status and COVID-19[J]. Int J Vitam<br /> Nutr Res, 2022, 92(1): 3.<br /> [7] Sertdemir AL, ?cli A, Aribas A, et al. Prognostic nutritional<br /> index and the risk of acute kidney injury in patients with acute<br /> coronary syndrome[J]. Rev Assoc Med Bras (1992), 2021, 67(8):<br /> 1124-1129.<br /> [8] Perou CM, S?rlie T, Eisen MB, et al. Molecular portraits of human<br /> breast tumours[J]. Nature, 2000, 406(6797): 747-752.<br /> [9] 赖艳梅, 祝琴, 赵雪云, 等. 预后营养指数对乳腺癌患者预后的<br /> 关系[J]. 大医生, 2020, 5(16): 116-118. [Lai YM, Zhu Q, Zhao<br /> XY, et al. Relationship Between Prognostic Nutritional Index and<br /> Prognosis of Breast Cancer Patients[J]. Da Yi Sheng, 2020, 5(16):<br /> 116-118.]<br /> [10] 单宏杰, 肖迎利, 周雷, 等. 预后营养指数与乳腺癌临床病理<br /> 关系研究[J]. 蚌埠医学院学报, 2019, 44(2): 212-214. [Shan<br /> HJ, Xiao YL, Zhou L, et al. Study on the relationship between<br /> the prognosis nutritional index and clinicopathology of breast<br /> carcinoma[J]. Bengbu Yi Xue Yuan Xue Bao, 2019, 44(2):<br /> 212-214.]<br /> [11] Wu X, Ding M, Lin J. Three-microRNA expr‍ession signature<br /> predicts survival in triple-negative breast cancer[J]. Oncol Lett,<br /> 2020, 19(1): 301-308.<br /> [12] Yang Z, Zhang B, Hou LK, et al. Pre-operative prognostic<br /> nutritional index predicts the outcomes for triple-negative breast<br /> cancer[J]. Tumour Biol, 2014, 35(12): 12165-12171.<br /> [13] Mohri T, Mohri Y, Shigemori T, et al. Impact of prognostic<br /> nutritional index on long-term outcomes in patients with breast<br /> cancer[J]. World J Surg Oncol, 2016, 14(1): 170.<br /> [14] Frasier LL, Holden S, Holden T, et al. Temporal Trends in<br /> Postmastectomy Radiation Therapy and Breast Reconstruction<br /> Associated With Changes in National Comprehensive Cancer<br /> Network Guidelines[J]. JAMA Oncol, 2016, 2(1): 95-101.<br /> [15] Hua X, Long ZQ, Huang X, et al. The Value of Prognostic<br /> Nutritional Index (PNI) in Predicting Survival and Guiding<br /> Radiotherapy of Patients With T1-2N1 Breast Cancer[J]. Front<br /> Oncol, 2019, 9: 1562.<br /> [16] Kerr J, Anderson C, Lippman SM. Physical activity, sedentary<br /> behaviour, diet, and cancer: an update and emerging new<br /> evidence[J]. Lancet Oncol, 2017, 18(8): e457-e471.<br /> [17] Okadome K, Baba Y, Yagi T, et al. Prognostic Nutritional Index,<br /> Tumor-infiltrating Lymphocytes, and Prognosis in Patients with<br /> Esophageal Cancer[J]. Ann Surg, 2020, 271(4): 693-700.<br /> [18] Wang Y, Battseren B, Yin W, et al. Predictive and prognostic<br /> value of prognostic nutritional index for locally advanced breast<br /> cancer[J]. Gland Surg, 2019, 8(6): 618-626.<br /> [19] Tokunaga R, Sakamoto Y, Nakagawa S, et al. CONUT: a novel<br /> independent predictive score for colorectal cancer patients<br /> undergoing potentially curative resection[J]. Int J Colorectal Dis,<br /> 2017, 32(1): 99-106.<br /> [20] Harimoto N, Yoshizumi T, Sakata K, et al. Prognostic Significance<br /> of Preoperative Controlling Nutritional Status (CONUT) Score<br /> in Patients Undergoing Hepatic Resection for Hepatocellular<br /> Carcinoma[J]. World J Surg, 2017, 41(11): 2805-2812.<br /> [21] Y?lmaz A, Tekin SB, Bilici M, et al. The Significance of<br /> Controlling Nutritional Status (CONUT) Score as a Novel<br /> Prognostic Parameter in Small Cell Lung Cancer[J]. Lung, 2020,<br /> 198(4): 695-704.<br /> [22] Li W, Li M, Wang T, et al. Controlling Nutritional Status (CONUT)<br /> score is a prognostic factor in patients with resected breast<br /> cancer[J]. Sci Rep, 2020, 10(1): 6633.<br /> [23] Takahashi T, Watanabe T, Otaki Y, et al. Prognostic significance of<br /> the controlling nutritional (CONUT) score in patients with acute<br /> coronary syndrome[J]. Heart Vessels, 2021, 36(8): 1109-1116.<br /> [24] Bengelloun AK, Ortega GJ, Ancochea J, et al. Usefulness of the<br /> CONUT index upon hospital admission as a potential prognostic<br /> indicator of COVID-19 health outcomes[J]. Chin Med J (Engl),<br /> 2021, 135(2): 187-193.<br /> [25] Huang ZZ, Song CG, Huang JJ, et al. Prognostic significance of<br /> the Controlling Nutritional Status (CONUT) score in surgically<br /> treated breast cancer patients[J]. Gland Surg, 2020, 9(5):<br /> 1370-1379.<br /> [26] Ishihara H, Kondo T, Yoshida K, et al. Preoperative controlling<br /> nutritional status (CONUT) score as a novel predictive biomarker<br /> of survival in patients with localized urothelial carcinoma of the<br /> upper urinary tract treated with radical nephroureterectomy[J].<br /> Urol Oncol, 2017, 35(9): 539.e9-539.e16.<br /> [27] Yang Z, Zheng Y, Wu Z, et al. Association between pre-diagnostic<br /> serum albumin and cancer risk: Results from a prospective<br /> population-based study[J]. Cancer Med, 2021, 10(12): 4054-4065.<br /> [28] Liu X, Meng QH, Ye Y, et al. Prognostic significance of<br /> pretreatment serum levels of albumin, LDH and total bilirubin<br /> in patients with non-metastatic breast cancer[J]. Carcinogenesis,<br /> 2015, 36(2): 243-248.<br /> [29] Singh N, Baby D, Rajguru JP, et al. Inflammation and<br /> cancer[J]. Ann Afr Med, 2019, 18(3): 121-126.<br /> [30] 徐良, 张百红. 淋巴细胞相关炎性反应指标与乳腺癌预后的相<br /> 关性[J]. 肿瘤防治研究, 2020, 47(12): 936-941. [Xu L, Zhang<br /> BH. Prognostic Value of Lymphocyte-associated Inflammatory<br /> Markers in Breast Cancer[J]. Zhong Liu Fang Zhi Yan Jiu, 2020,<br /> 47(12): 936-941.]<br /> [31] Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation<br /> index predicts prognosis of patients after curative resection for<br /> hepatocellular carcinoma[J]. Clin Cancer Res, 2014, 20(23):<br /> 6212-6222.<br /> [32] Jiang C, Lu Y, Zhang S, et al. Systemic Immune-Inflammation<br /> Index Is Superior to Neutrophil to Lymphocyte Ratio in<br /> Prognostic Assessment of Breast Cancer Patients Undergoing<br /> Neoadjuvant Chemotherapy[J]. Biomed Res Int, 2020, 2020:<br /> 7961568.
Related articles from Frontiers Journals
[1] WANG Hua, HU Xiaolei, LI Xingyu, DAI Ying. Advances in Combined Immunotherapy for Triple Negative Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(10): 996-1002.
[2] WANG Yu, KANG Hua. Assessment and Management of Axillary Lymph Nodes for Breast Cancer Under Concept of Precision Therapy[J]. Cancer Research on Prevention and Treatment, 2022, 49(10): 1003-1009.
[3] RUI Yiqi, DENG Fei, WANG Wenwen, XU Hua, LI Xiaowei, DING Yongbin, FAN Shulin. Effects of Linc00460 on Aerobic Glycolysis in Breast Cancer Cells via Sponge Adsorption of miR-320a[J]. Cancer Research on Prevention and Treatment, 2022, 49(10): 1037-1042.
[4] LIU Yao, SUN Xuemei, LIU Jing, LIU Wei, LYU Fei, LIU Yueping. Expression of FGL1, Distribution of Tumor-Infiltrating Lymphocytes, and Their Clinical Significance in Esophageal Squamous-Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2022, 49(10): 1043-1047.
[5] XIONG Yudi, ZHANG Xue, ZOU Ning, MOU Jingjing, LI Benhui, CHEN Weidong, LIAO Lingxia, ZHANG Jiucheng. A Prospective PhaseⅠ Clinical Study of Docetaxel with Concurrent Late-course Hyperfractionated Radiotherapy After Breast-conserving Surgery for Stage T1-T2 Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(10): 1054-1058.
[6] GUO Xin, DU Hua, SHI Yingxu, . Exosomal Delivery of Non-coding RNA Regulates Breast Bancer Drug Resistance[J]. Cancer Research on Prevention and Treatment, 2022, 49(10): 1071-1076.
[7] LI Jinzhou, WANG Wenjie, YAO Yalong, MU Yanxi, CHEN Kang, SHEN Yimin, WANG Zhou, HUANG Zeping, CHEN Xiao. Development and Validation of Prognostic Nomogram Based on Negative Lymph Node Count for Patients with Gastric Signet Ring Cell Carcinoma#br#[J]. Cancer Research on Prevention and Treatment, 2022, 49(09): 923-930.
[8] HUANG Zhenghua, ZHOU Jian, LI Yufu, LIU Yanyan, ZHOU Keshu, SONG Yongping. Clinical Efficacy and Prognostic Factors of Autologous Hematopoietic Stem Cell Transplantation for Hodgkin’s Lymphoma in 38 Cases[J]. Cancer Research on Prevention and Treatment, 2022, 49(09): 952-955.
[9] CHANG Jinyi, WANG Wei, CAI Haifeng. Research Progress of PD-1/PD-L1 Inhibitor Combined with Trastuzumab in HER2-positive Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(09): 965-969.
[10] WANG Ya’nan, LU Wenping, MEI Heting, CUI Yongjia, ZHUO Zhili. Risk of Recurrence or Metastasis of Breast Cancer by LNG-IUS: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2022, 49(08): 786-791.
[11] JIA Lijuan, ZHANG Yunqiang, ZHANG Baihong, YUE Hongyun. Expression and Clinical Significance of m6A Methylatransferase ZC3H13 in Gastric Cancer Tissues and Serum[J]. Cancer Research on Prevention and Treatment, 2022, 49(08): 792-798.
[12] SUI Daxing, WANG Xueying, ZHANG Jiaxin. A New N-staging System for Predicting Postoperative Survival of M0 Stage Inflammatory Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(08): 799-805.
[13] LI Jinzhou, HUANG Zeping, MU Yanxi, YAO Yalong, WANG Wenjie, LIU Haipeng, LIU Jie, WANG Zhou, CHEN Xiao. Prognostic Value of Negative Lymph Nodes Count in Solid Tumors[J]. Cancer Research on Prevention and Treatment, 2022, 49(08): 843-849.
[14] ZHOU Silei, SUN Guanqun, ZENG Tanlun, CHENG Zhuo, LIANG Xijun. Expression and Prognostic Value of CK2α' in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2022, 49(07): 662-666.
[15] XIA Lili, ZHU Xinyi, ZHANG Xiwei, LI Zhengjiang, LIU Shaoyan, LU Haizhen, AN Changming. Predictive Value of Depth of Invasion of Tongue Squamous Cell Carcinoma for Cervical Lymph Node Metastasis and Prognosis[J]. Cancer Research on Prevention and Treatment, 2022, 49(07): 675-681.
Full text